Expert National Meeting
BRINGING IMMUNOSCIENCE TO THE CLINIC
10 January 2024
Materials from past ISA meetings are only available for your information, it reflects the state of sciences at the time of the meeting.
In the context of 5 years of ImmunoScience Academy, the national meeting entitled “Bringing ImmunoScience to the Clinic” covered immunotherapy in earlier stages of malignancies, novel concepts in oncology such as gut microbiome and bispecifics, and relevant topics for the day-to-day clinical practice.
MOVING CANCER IMMUNOTHERAPY TOWARDS EARLIER STAGES OF DISEASE
Theory and practice
Prof Pierre Coulie, President of the ImmunoScience Academy —
de Duve Institute — UCL
Prof Ahmad Awada — Jules Bordet Institute — HUB
WHAT’S NEW IN TREATING IMMUNOTHERAPY-TOXICITY IN 2024?
Dr Stefan Rauh — CHEM Luxemburg
Prof Sandrine Aspeslagh— UZ Brussel
WHEN TO STOP OR RESUME IMMUNOTHERAPY? DATA FORM MELANOMA, LUNG AND GI CANCER
Prof Eric Van Cutsem — UZ Leuven
Prof Johan Vansteenkiste — UZ Leuven
Prof Bart Neyns — UZ Brussel
IMAGING FOR IMMUNOTHERAPY MANAGEMENT, WHAT SHOULD YOU KNOW FOR CLINICAL PRACTICE?
Dr François Cousin — CHU Liège
Prof Vincent Vandecaveye — UZ Leuven
Moderator: Prof Guy Jerusalem — CHU Liège
RAPID EMERGENCE OF THE GUT MICROBIOME IN CANCER IMMUNOTHERAPY
Dr Bertrand Routy — Montréal Canada
Moderator: Dr Stefan Rauh — CHEM Luxemburg
NOVELTIES IN BISPECIFIC AGENTS FOR HEMATOLOGY AND SOLID TUMORS
Prof Tessa Kerre — UZ Gent
Moderator: Dr Stefan Rauh — CHEM Luxemburg
DRUG INTERFERENCE DURING IMMUNOTHERAPY
Dr Bertrand Routy — Montréal Canada
Dr Maxime Ilzkovitz — Jules Bordet Institute – HUB
Moderator: Prof Ahmad Awada — Jules Bordet Institute – HUB
PATIENT EDUCATION: EXAMPLES FROM ACADEMIC CENTERS IN BELGIUM
Prof Tessa Kerre — UZ Gent
Dr Sylvie Streel — CHU Liège
Mrs Marie Vandevelde — UZ Leuven
Moderator: Prof Johan Vansteenkiste — UZ Leuven
CAR T VS BISPECIFICS: HOW TO MANAGE TOXICITY AND SEQUENCING
Prof Jo Caers — CHU Liège
Prof Peter Vandenberghe — UZ Leuven
Moderator: Prof Rik Schots — UZ Brussel